Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLHL3 Activators

KLHL3 Activators are a diverse set of chemical compounds that enhance the protein's regulatory functions in electrolyte balance and blood pressure homeostasis. Sodium Chloride, in hypertonic doses, and Lithium can perturb the WNK-SPAK/OSR1 pathway, which is crucial for ion transport in the kidney, thereby indirectly necessitating increased KLHL3-mediated ubiquitination to restore homeostasis. Aldosterone antagonists like EKLHL3 Activators are a diverse set of chemical compounds that enhance the protein's regulatory functions in electrolyte balance and blood pressure homeostasis. Sodium Chloride, in hypertonic doses, and Lithium can perturb the WNK-SPAK/OSR1 pathway, which is crucial for ion transport in the kidney, thereby indirectly necessitating increased KLHL3-mediated ubiquitination to restore homeostasis. Aldosterone antagonists like Eplerenone, along with diuretics such as Hydrochlorothiazide and Chlorthalidone, challenge the salt-retaining mechanisms, thereby enhancing the role of KLHL3 in modulating the degradation of the Na-Cl cotransporter (NCC) to maintain blood pressure and electrolyte balance. Moreover, the engagement of RAAS components by Angiotensin II, and its receptor blockers such as Losartan, Candesartan, and Valsartan, indirectly calls upon KLHL3's activity to counterbalance the shifts in homeostatic control exerted by this system.

The functional enhancement of KLHL3 is also influenced by compounds that affect sodium reabsorption channels. Amiloride and Triamterene, by inhibiting epithelial sodium channels (ENaC), indirectly promote KLHL3 activity to adjust the homeostatic balance. This compensatory effect ensures that KLHL3 activity is upregulated to maintain sodium equilibrium when ENaC is inhibited. The collective actions of these chemicals not only underscore the vital role of KLHL3 in kidney function and systemic blood pressure regulation but also highlight the intricacies of ion transport modulation. Through their targeted effects on various signaling pathways and ion transport mechanisms, these activators enhance the function of KLHL3, thereby facilitating the maintenance of electrolyte balance and vascular tone without altering the protein's expression levels or direct activation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Angiotensin II, Human

4474-91-3sc-363643
sc-363643A
sc-363643B
sc-363643C
1 mg
5 mg
25 mg
100 mg
$50.00
$75.00
$260.00
$505.00
3
(1)

Angiotensin II interacts with its receptor to potentiate the activity of the WNK-SPAK/OSR1 pathway. As KLHL3 targets WNK for degradation, the presence of Angiotensin II might enhance KLHL3's activity to maintain homeostasis by regulating this pathway and preventing overactivation.

Aldosterone

52-39-1sc-210774
sc-210774A
sc-210774B
sc-210774C
sc-210774D
sc-210774E
2 mg
5 mg
10 mg
50 mg
100 mg
250 mg
$254.00
$209.00
$311.00
$1520.00
$3014.00
$7487.00
1
(1)

Aldosterone is involved in the regulation of sodium and potassium balance. Its action may increase the functional demand on KLHL3 for the degradation of WNK kinases, indirectly enhancing KLHL3's activity to maintain electrolyte balance.

Amiloride

2609-46-3sc-337527
1 g
$290.00
7
(1)

Amiloride inhibits sodium channels in the distal nephron. This can indirectly upregulate KLHL3 activity as the body tries to counteract the effects of the drug by modulating the WNK-SPAK/OSR1 signaling pathway.

Hydrochlorothiazide

58-93-5sc-207738
sc-207738A
sc-207738B
sc-207738C
sc-207738D
5 g
25 g
50 g
100 g
250 g
$54.00
$235.00
$326.00
$551.00
$969.00
(0)

Hydrochlorothiazide is a diuretic that could indirectly enhance KLHL3 activity by causing alterations in electrolyte reabsorption that would require KLHL3-mediated regulation of WNK kinase levels.

Eplerenone

107724-20-9sc-203943
sc-203943A
10 mg
50 mg
$108.00
$612.00
4
(1)

Eplerenone, a selective aldosterone blocker, may indirectly enhance KLHL3 activity by affecting the WNK-SPAK/OSR1 pathway, which KLHL3 is known to regulate.

Ouabain-d3 (Major)

sc-478417
1 mg
$506.00
(0)

Ouabain is a Na+/K+-ATPase inhibitor, which could lead to compensatory mechanisms that enhance KLHL3 activity to regulate ion homeostasis.

Captopril

62571-86-2sc-200566
sc-200566A
1 g
5 g
$48.00
$89.00
21
(1)

Captopril, an ACE inhibitor, could indirectly enhance KLHL3 activity by modulating the renin-angiotensin-aldosterone system, affecting the electrolyte balance and thus KLHL3's role in it.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

Losartan, an angiotensin II receptor antagonist, might enhance KLHL3 activity indirectly by modulating the downstream effects on the WNK-SPAK/OSR1 pathway.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$58.00
$170.00
15
(1)

Nifedipine, a calcium channel blocker, could indirectly enhance KLHL3 activity by affecting calcium signaling pathways that intersect with KLHL3's regulatory functions.

Metolazone

17560-51-9sc-211900
100 mg
$224.00
(1)

Metolazone, a diuretic affecting electrolyte reabsorption, could enhance KLHL3's ubiquitin ligase activity indirectly by altering the functional load on the WNK-SPAK/OSR1 pathway.